Category: Medical Device, Diagnostics

Overview: Nimble Science simplifies the triage of patients presenting with chronic GI conditions with precision microbial evidence. The SIMBA test leverages our first in kind passive capsule that collects endoscopic quality liquid biopsies directly from the small intestine with a simple at home kit.

System Benefits:

• Irritable bowel syndrome (IBS) is a costly diagnosis of exclusion affecting nearly 20% of the Canadian population
• Status-quo processes leave over 50% of patients undiagnosed resulting in repeated primary care visits, estimated at 11% of all visits.
• Prescribed antibiotic treatments are costly and without microbial profiling only 40% effective.
• To rule out Inflammatory Bowel Disease, The SIMBA test costs 90% less than when patients first need to undergo an in-clinic endoscopy procedure.